Who treats adolescents and young adults with cancer? A report from the AYA HOPE study

Helen M. Parsons, Linda C. Harlan, Susanne Schmidt, Theresa H Keegan, Charles F. Lynch, Erin E. Kent, Xiao Cheng Wu, Stephen M. Schwartz, Roland L. Chu, Gretchen Keel, Ashley Wilder Smith

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Purpose: Physicians play a critical role in delivering effective treatment and enabling successful transition to survivorship among adolescent and young adult (AYA) cancer patients. However, with no AYA cancer medical specialty, information on where and by whom AYAs with cancer are treated is limited. Methods: Using the National Cancer Institute's population-based AYA HOPE Study, 464 AYAs aged 15-39 at diagnosis treated by 903 physicians were identified. Differences in physician and hospital characteristics were examined by age at diagnosis and cancer type (germ cell cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphocytic leukemia [ALL], and sarcoma) using chi-square tests. Results: Treating physicians were predominately 51-64 years old, male, United States-trained in non-pediatric specialties, and in group practices within large metropolitan areas. Older patients were less often treated by pediatric physicians (p < 0.01) and more likely to be treated by United States-trained physicians without research/teaching responsibilities and in hospitals without residency programs (p < 0.05). The majority of the few pediatricians (n = 44) treated ALL patients. Physicians with research/teaching responsibilities and those based in medical schools were more likely to treat patients with ALL and sarcoma compared with other cancer types (p < 0.01). Of HL patients, 73% were treated at a cancer center compared with 56% of patients with germ cell cancer (p < 0.01), while ALL (85%) and sarcoma (87%) patients were more likely to be treated in hospitals with residency programs (p < 0.01). Conclusions: Most AYAs with cancer were treated by non-pediatric physicians in community settings, although physician characteristics varied significantly by patient cancer type and age at diagnosis.

Original languageEnglish (US)
Pages (from-to)141-150
Number of pages10
JournalJournal of Adolescent and Young Adult Oncology
Volume4
Issue number3
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

Fingerprint

Young Adult
Physicians
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Neoplasms
Sarcoma
Germ Cell and Embryonal Neoplasms
Internship and Residency
Teaching
Group Practice
National Cancer Institute (U.S.)
Chi-Square Distribution
Medical Schools
Hodgkin Disease
Research
Non-Hodgkin's Lymphoma
Survival Rate
Medicine
Pediatrics
Population

Keywords

  • AYA HOPE Study
  • physicians
  • place of care
  • treatment

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health

Cite this

Who treats adolescents and young adults with cancer? A report from the AYA HOPE study. / Parsons, Helen M.; Harlan, Linda C.; Schmidt, Susanne; Keegan, Theresa H; Lynch, Charles F.; Kent, Erin E.; Wu, Xiao Cheng; Schwartz, Stephen M.; Chu, Roland L.; Keel, Gretchen; Smith, Ashley Wilder.

In: Journal of Adolescent and Young Adult Oncology, Vol. 4, No. 3, 01.09.2015, p. 141-150.

Research output: Contribution to journalArticle

Parsons, HM, Harlan, LC, Schmidt, S, Keegan, TH, Lynch, CF, Kent, EE, Wu, XC, Schwartz, SM, Chu, RL, Keel, G & Smith, AW 2015, 'Who treats adolescents and young adults with cancer? A report from the AYA HOPE study', Journal of Adolescent and Young Adult Oncology, vol. 4, no. 3, pp. 141-150. https://doi.org/10.1089/jayao.2014.0041
Parsons, Helen M. ; Harlan, Linda C. ; Schmidt, Susanne ; Keegan, Theresa H ; Lynch, Charles F. ; Kent, Erin E. ; Wu, Xiao Cheng ; Schwartz, Stephen M. ; Chu, Roland L. ; Keel, Gretchen ; Smith, Ashley Wilder. / Who treats adolescents and young adults with cancer? A report from the AYA HOPE study. In: Journal of Adolescent and Young Adult Oncology. 2015 ; Vol. 4, No. 3. pp. 141-150.
@article{10927fc7e01e46b196b73adc51283958,
title = "Who treats adolescents and young adults with cancer? A report from the AYA HOPE study",
abstract = "Purpose: Physicians play a critical role in delivering effective treatment and enabling successful transition to survivorship among adolescent and young adult (AYA) cancer patients. However, with no AYA cancer medical specialty, information on where and by whom AYAs with cancer are treated is limited. Methods: Using the National Cancer Institute's population-based AYA HOPE Study, 464 AYAs aged 15-39 at diagnosis treated by 903 physicians were identified. Differences in physician and hospital characteristics were examined by age at diagnosis and cancer type (germ cell cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphocytic leukemia [ALL], and sarcoma) using chi-square tests. Results: Treating physicians were predominately 51-64 years old, male, United States-trained in non-pediatric specialties, and in group practices within large metropolitan areas. Older patients were less often treated by pediatric physicians (p < 0.01) and more likely to be treated by United States-trained physicians without research/teaching responsibilities and in hospitals without residency programs (p < 0.05). The majority of the few pediatricians (n = 44) treated ALL patients. Physicians with research/teaching responsibilities and those based in medical schools were more likely to treat patients with ALL and sarcoma compared with other cancer types (p < 0.01). Of HL patients, 73{\%} were treated at a cancer center compared with 56{\%} of patients with germ cell cancer (p < 0.01), while ALL (85{\%}) and sarcoma (87{\%}) patients were more likely to be treated in hospitals with residency programs (p < 0.01). Conclusions: Most AYAs with cancer were treated by non-pediatric physicians in community settings, although physician characteristics varied significantly by patient cancer type and age at diagnosis.",
keywords = "AYA HOPE Study, physicians, place of care, treatment",
author = "Parsons, {Helen M.} and Harlan, {Linda C.} and Susanne Schmidt and Keegan, {Theresa H} and Lynch, {Charles F.} and Kent, {Erin E.} and Wu, {Xiao Cheng} and Schwartz, {Stephen M.} and Chu, {Roland L.} and Gretchen Keel and Smith, {Ashley Wilder}",
year = "2015",
month = "9",
day = "1",
doi = "10.1089/jayao.2014.0041",
language = "English (US)",
volume = "4",
pages = "141--150",
journal = "Journal of Adolescent and Young Adult Oncology",
issn = "2156-5333",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Who treats adolescents and young adults with cancer? A report from the AYA HOPE study

AU - Parsons, Helen M.

AU - Harlan, Linda C.

AU - Schmidt, Susanne

AU - Keegan, Theresa H

AU - Lynch, Charles F.

AU - Kent, Erin E.

AU - Wu, Xiao Cheng

AU - Schwartz, Stephen M.

AU - Chu, Roland L.

AU - Keel, Gretchen

AU - Smith, Ashley Wilder

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Purpose: Physicians play a critical role in delivering effective treatment and enabling successful transition to survivorship among adolescent and young adult (AYA) cancer patients. However, with no AYA cancer medical specialty, information on where and by whom AYAs with cancer are treated is limited. Methods: Using the National Cancer Institute's population-based AYA HOPE Study, 464 AYAs aged 15-39 at diagnosis treated by 903 physicians were identified. Differences in physician and hospital characteristics were examined by age at diagnosis and cancer type (germ cell cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphocytic leukemia [ALL], and sarcoma) using chi-square tests. Results: Treating physicians were predominately 51-64 years old, male, United States-trained in non-pediatric specialties, and in group practices within large metropolitan areas. Older patients were less often treated by pediatric physicians (p < 0.01) and more likely to be treated by United States-trained physicians without research/teaching responsibilities and in hospitals without residency programs (p < 0.05). The majority of the few pediatricians (n = 44) treated ALL patients. Physicians with research/teaching responsibilities and those based in medical schools were more likely to treat patients with ALL and sarcoma compared with other cancer types (p < 0.01). Of HL patients, 73% were treated at a cancer center compared with 56% of patients with germ cell cancer (p < 0.01), while ALL (85%) and sarcoma (87%) patients were more likely to be treated in hospitals with residency programs (p < 0.01). Conclusions: Most AYAs with cancer were treated by non-pediatric physicians in community settings, although physician characteristics varied significantly by patient cancer type and age at diagnosis.

AB - Purpose: Physicians play a critical role in delivering effective treatment and enabling successful transition to survivorship among adolescent and young adult (AYA) cancer patients. However, with no AYA cancer medical specialty, information on where and by whom AYAs with cancer are treated is limited. Methods: Using the National Cancer Institute's population-based AYA HOPE Study, 464 AYAs aged 15-39 at diagnosis treated by 903 physicians were identified. Differences in physician and hospital characteristics were examined by age at diagnosis and cancer type (germ cell cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphocytic leukemia [ALL], and sarcoma) using chi-square tests. Results: Treating physicians were predominately 51-64 years old, male, United States-trained in non-pediatric specialties, and in group practices within large metropolitan areas. Older patients were less often treated by pediatric physicians (p < 0.01) and more likely to be treated by United States-trained physicians without research/teaching responsibilities and in hospitals without residency programs (p < 0.05). The majority of the few pediatricians (n = 44) treated ALL patients. Physicians with research/teaching responsibilities and those based in medical schools were more likely to treat patients with ALL and sarcoma compared with other cancer types (p < 0.01). Of HL patients, 73% were treated at a cancer center compared with 56% of patients with germ cell cancer (p < 0.01), while ALL (85%) and sarcoma (87%) patients were more likely to be treated in hospitals with residency programs (p < 0.01). Conclusions: Most AYAs with cancer were treated by non-pediatric physicians in community settings, although physician characteristics varied significantly by patient cancer type and age at diagnosis.

KW - AYA HOPE Study

KW - physicians

KW - place of care

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85006219534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006219534&partnerID=8YFLogxK

U2 - 10.1089/jayao.2014.0041

DO - 10.1089/jayao.2014.0041

M3 - Article

C2 - 26421222

AN - SCOPUS:85006219534

VL - 4

SP - 141

EP - 150

JO - Journal of Adolescent and Young Adult Oncology

JF - Journal of Adolescent and Young Adult Oncology

SN - 2156-5333

IS - 3

ER -